surmount-1 trial tirzepatide obesity without diabetes weight loss once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide for Older Adults with

Every milliliter of solution now contains 5mg of tirzepatide

A patient with chronic nausea needs a slower titration plan

These gastrointestinal side effects typically improve within the first 2 months of treatment as physiological adaptation occurs. Expected Timeline: Weeks 1-4 : Peak intensity, especially after starting medication or dose increases Weeks 4-8 : Gradual improvement as the body adjusts to delayed gastric emptying Week 8+: 80% of cases show significant resolution Persistent cases : May require dose adjustments or alternative treatments Sulfur burps are normal on Wegovy and other GLP-1 medications as the digestive system adapts to slower gastric motility

Waldron, James, Fierce Biotechs top 10 editors picks for 2024, Fierce Biotech, 23 Dec, 2024, 13

Many adverse events from semaglutide are linked to accidental overdoses rather than normal therapeutic dosing